InsidersTradesSigma
Browse the complete record of transactions filed by KELLY RALPH DAVID, Director. Director active across 1 companies, notably Invesco Real Estate Income Trust Inc.. In total, 2 disclosures have been logged. The latest transaction was disclosed on 1 December 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.
2 of 2 declarations
Ralph David Kelly is the General Counsel at Akero Therapeutics, Inc. He oversees legal and regulatory matters, ensuring the company's compliance. His expertise is essential for managing legal risks.